Negotiators representing Big Pharma and the U.S. Food and Drug Administration are close to a deal on raising fees paid by industry to speed up reviews of direct-to-consumer advertising. A spokesperson for the trade group BioCentury said that the FDA is seeking to raise about $6.2 million per year, putting individual application review fees at about $41,000.

The Leader of the New Zealand National Party, Don Bracks, has indicated that he may clear the way for the publication of a book by investigative journalist Nicky Hager, despite having obtained an injunction last Friday banning anyone from publishing the contents of leaked internal party emails.